|Articles|May 1, 2016
- Pharmaceutical Executive-05-01-2016
- Volume 36
- Issue 5
Pharmaceutical Executive, May 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 10 years ago
Steering the Change: GSK's Jack Baileyabout 10 years ago
Pharma’s Big Push for Valueabout 10 years ago
Pharm Exec at the Vantage Pointabout 10 years ago
Pharma Under Pressure to Curb Opioid Abuseabout 10 years ago
Country Report: Franceabout 10 years ago
Pharma Under Fire for Driving "Opioid Abuse Epidemic"Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
5